Omalizumab for treatment of idiopathic angioedema
Vinay Goswamy, Kristine E. Lee, Elizabeth M. McKernan, Paul S. Fichtinger, Sameer K. Mathur, Ravi Viswanathan
Topics & Concepts
AngioedemaMedicineOmalizumabPlaceboOdds ratioRandomized controlled trialVisual analogue scaleConfidence intervalDermatology Life Quality IndexClinical endpointInternal medicineQuality of life (healthcare)Hereditary angioedemaDermatologySurgeryImmunologyDiseaseImmunoglobulin EPathologyAntibodyAlternative medicineNursingUrticaria and Related ConditionsCoagulation, Bradykinin, Polyphosphates, and AngioedemaDrug-Induced Adverse Reactions